Welcome to the e-CCO Library!

DOP003: Gene expression profiling indicates similar molecular pathways are active in adult and paediatric ulcerative colitis
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

K. Li*1, J. Ouahed2, J. Friedman1, R. Strauss1, D. Chan1, S. Telesco1, D. Shouval3, J. Canavan4, C. Brodmerkel1, S. Snapper5

Created: Friday, 22 February 2019, 9:49 AM
DOP003: Gene Expression Profiling Indicates Similar Molecular Pathways Are Active in Adult And Pediatric Ulcerative Colitis
Year: 2016
Source: ECCO'16 DOP
Authors: Li K.
genetics, Ulcerative Colitis, paediatric
Files: 1
DOP003: Proximal disease extension in patients with limited ulcerative colitis: a Danish population-based inception cohort
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Burisch J.*1, Vind I.2, Prosberg M.2, Colombel J.-F.3, Ungaro R.3, Bendtsen F.2, Vester-Andersen M.2,4

Created: Wednesday, 20 February 2019, 10:36 AM
DOP003: Proximal disease extension in patients with limited Ulcerative Colitis: a Danish population-based inception cohort
Year: 2017
Source: ECCO'17 Barcelona
Authors: Burisch J.
Natural history, Ulcerative colitis, Montreal classification
Files: 1
DOP003: Ustekinumab induces clinical and biological remission in biologic refractory Crohn’s disease patients: A real-world belgian cohort study
Year: 2018
Source: ECCO '18 Vienna
Authors:

C. Liefferinckx1,2*, B. Verstockt3, A. Gils4, M. Noman3, C. Van Kemseke5, E. Macken6, M. De Vos7, W. Van Moerkercke8, J.-F. Rahier9, P. Bossuyt10, J. Dutré11, E. Humblet12, D. Staessen13, H. Peeters14, P. Van Hootegem15, E. Louis5, D. Franchimont1,2, F. Baert16, S. Vermeire3

Created: Thursday, 21 February 2019, 9:14 AM
DOP003: Ustekinumab induces clinical and biological remission in biologic refractory Crohn's Disease patients: A real world belgian cohort study
Year: 2018
Source: ECCO'18 Vienna
Authors: Liefferinckx Claire
Created: Tuesday, 8 May 2018, 11:36 AM
Files: 1
DOP004: Epigenetic control of colonic epithelial antigen processing, barrier function, and the microbiome via methyl-CpG binding domain protein 2
Year: 2016
Source: ECCO'16 DOP
Authors: Jones G.
epithelial cell, genetics, lymphocyte, microbiota, epigenetics
Files: 1
DOP004: Epigenetic control of colonic epithelial antigen processing, barrier function, and the microbiome via methyl-CpG binding domain protein 2
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

G.-R. Jones*1, A. MacDonald2, P. Cook2

Created: Friday, 22 February 2019, 9:49 AM
DOP004: Ethnicity and country of birth are associated with phenotypic differences in patients with inflammatory bowel disease
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Spekhorst L.*1,2, Severs M.3, de Boer N.K.H.4, Festen E.A.M.1,2, Fidder H.H.3, Hoentjen F.5, Imhann F.1,2, de Jong D.J.5, van der Meulen-de Jong A.E.6, Pierik M.7, van der Woude C.J.8, Dijkstra G.1, Ponsioen C.Y.9, Lowenberg M.9, Oldenburg B.3, Weersma R.K.1

Created: Wednesday, 20 February 2019, 10:36 AM
DOP004: Ethnicity and country of birth are associated with phenotypic differences in patients with Inflammatory Bowel Disease
Year: 2017
Source: ECCO'17 Barcelona
Authors: Spekhorst L.
environmental factors, Genetic factors, Crohn's disease, Ulcerative colitis, Montreal Classification
Files: 1
DOP004: Long-term safety of adalimumab in patients with moderate-to-severe ulcerative colitis: Interim results of a non-interventional registry, LEGACY
Year: 2018
Source: ECCO '18 Vienna
Authors:

P. Bossuyt1*, R. Atreya2, C. Taxonera3,4, X. Hebuterne5,6, K. Isaacs7, P.D. Higgins8, J. Lindsay9, G. Heap10, D. Arikan10, V. Kuehnl11, J. Petersson10, A.M. Robinson10, E.V. Loftus Jr.12

Created: Thursday, 21 February 2019, 9:14 AM
DOP005: A role for IL1 in mediating intestinal inflammation in IL10 receptor deficiency in mice and humans
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

D. Shouval*1, 2, A. Biswas2, Y.-H. Kang2, A. Griffith2, B. Horwitz2, A. Bousvaros2, S. Snapper2

Created: Friday, 22 February 2019, 9:49 AM
DOP005: Proximal disease extension in limited ulcerative colitis: a systematic review and meta-analysis
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Roda G.*1, Narula N.2, Pinotti R.3, Skamnelos A.4, Katsanos K.4, Torres J.5, Ungaro R.6, Colombel J.-F.7

Created: Wednesday, 20 February 2019, 10:36 AM
DOP005: Proximal disease extension in limited Ulcerative Colitis: A systematic review and meta-analysis
Year: 2017
Source: ECCO'17 Barcelona
Authors: Roda G.
Natural history, Ulcerative colitis, Montreal classification
Files: 1
DOP005: Safety of vedolizumab in patients naïve to treatment with TNF antagonists compared with patients with prior use of TNF antagonists
Year: 2018
Source: ECCO '18 Vienna
Authors:

R. Cohen1, F. Bhayat2*, G. Hantsbarger2, A. Blake3, S. Vermeire4

Created: Thursday, 21 February 2019, 9:14 AM
DOP005: Safety of vedolizumab in patients naïve to treatment with TNF antagonists compared with patients with prior use of TNF antagonists
Year: 2018
Source: ECCO'18 Vienna
Authors: Russell Cohen
Created: Tuesday, 8 May 2018, 11:36 AM
Files: 1
DOP006: A multicentre cohort study to assess the safety of vedolizumab for inflammatory bowel disease
Year: 2018
Source: ECCO '18 Vienna
Authors:

J. Meserve1, S. Aniwan2, J.L. Koliani-Pace3, P. Shashi4, A. Weiss5, D. Faleck6, A. Winters6, S. Chablaney6, G. Kochhar4, B. Boland1, S. Singh1, R. Hirten6, E. Shmidt6, M. Bohm7, S. V Sagi7, M. Fischer7, D. Lukin5, D. Hudesman8, S. Chang8, K. Sultan9, A. Swaminath10, N. Gupta11, S. Kane2, E.V. Loftus2, B. Shen4, B.E. Sands6, J.-F. Colombel6, C.A. Siegel3, W.J. Sandborn1, P.S. Dulai1*

Created: Thursday, 21 February 2019, 9:14 AM
DOP006: A multicentre cohort study to assess the safety of vedolizumab for Inflammatory Bowel Disease
Year: 2018
Source: ECCO'18 Vienna
Authors: Dulai Parambir S
Created: Tuesday, 8 May 2018, 11:36 AM
Files: 1
DOP006: Gut homing adipose tissue T-cells might influence intestinal barrier function in Crohn’s disease and obesity
Year: 2016
Source: ECCO'16 DOP
Authors: Jödicke L.
Crohn's Disease, lymphocyte
Files: 1